Visteon Corporation provided earnings guidance for the full year 2017 and 2018. For the year of 2017, the company expects sales in the range of USD 3.14 billion to USD 3.15 billion, adjusted EBITDA in the range of USD 365 million to USD 370 million against previously guided an adjusted EBITDA between USD 362 million to USD 370 million and adjusted free cash flow in the range of USD 145 million to USD 150 million, which is lower than what the company previously guided. This adjusted EBITDA includes the impact of lower-than-expected net enduring costs, certain IP settlements, impact of pricing and other operational matters. The company's cash flow was impacted by the timing of working capital, which will in turn benefit the company's cash flow in the first quarter of 2018, and higher capital expenditures. CapEx will be coming in at a little over 3% of revenues for 2017 due to 2 reasons: plant investments to support the new business growth; and second, higher capitalization of software development costs as the company moves toward more platform- and software-based technologies. For the year of 2018, the company expects sales in the range of USD 3.175 billion to USD 3.275 billion, adjusted EBITDA in the range of USD 370 million to USD 380 million, and adjusted free cash flow in the range of USD 160 million to USD 180 million.